David T Scadden

2.6k total citations · 1 hit paper
9 papers, 2.1k citations indexed

About

David T Scadden is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, David T Scadden has authored 9 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 4 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in David T Scadden's work include Immunotherapy and Immune Responses (3 papers), Toxin Mechanisms and Immunotoxins (2 papers) and Hematopoietic Stem Cell Transplantation (2 papers). David T Scadden is often cited by papers focused on Immunotherapy and Immune Responses (3 papers), Toxin Mechanisms and Immunotoxins (2 papers) and Hematopoietic Stem Cell Transplantation (2 papers). David T Scadden collaborates with scholars based in United States, Sweden and Australia. David T Scadden's co-authors include Ching‐Hsuan Tung, M. Lewin, David G. Cory, Nadia Carlesso, Ralph Weissleder, Xiaowu Tang, Ivona T. Olszak, Richard H. Evans, Mark C. Poznansky and Russell B. Foxall and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and Nature Biotechnology.

In The Last Decade

David T Scadden

9 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells

2000 1.4k citations M. Lewin, Nadia Carlesso et al. Nature Biotechnology profile →

Peers

Countries citing papers authored by David T Scadden

Since Specialization

Citations

This map shows the geographic impact of David T Scadden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David T Scadden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David T Scadden more than expected).

Fields of papers citing papers by David T Scadden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David T Scadden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David T Scadden. The network helps show where David T Scadden may publish in the future.

Co-authorship network of co-authors of David T Scadden

This figure shows the co-authorship network connecting the top 25 collaborators of David T Scadden. A scholar is included among the top collaborators of David T Scadden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David T Scadden. David T Scadden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Defocus Corrected Large Area Cryo-EM (DeCo-LACE) for label-free detection of molecules across entire cell sections 2022 ·eLife ·Johannes Elferich, Giulia Schiroli, David T Scadden, Nikolaus Grigorieff	11
2	A transcriptional metastatic signature predicts survival in clear cell renal cell carcinoma 2022 ·Zenodo (CERN European Organization for Nuclear Research) ·(unknown), Shenglin Mei, (unknown), Taghreed Hirz, Youmna Kfoury, Douglas M. Dahl, Chin‐Lee Wu, Alexander O. Subtelny, Shulin Wu, David T Scadden, John H. Shin, Philip J. Saylor, David B. Sykes, Peter V. Kharchenko, Ninib Baryawno	3
3	Distinctive Mesenchymal-Parenchymal Cell Pairings Govern B Cell Differentiation in the Bone Marrow 2016 ·Stem Cell Reports ·Vionnie W.C. Yu, Stefania Lymperi, Toshihiko Oki, Alexandra M. E. Jones, Peter R. Swiatek, Radovan Vasic, Francesca Ferraro, David T Scadden	38
4	Non-genotoxic conditioning for hematopoietic stem cell transplantation using a hematopoietic-cell-specific internalizing immunotoxin 2016 ·Nature Biotechnology ·Rahul Palchaudhuri, Borja Sáez, Jonathan Hoggatt, Amir Schajnovitz, David B. Sykes, Tiffany Tate, Agnieszka Czechowicz, Youmna Kfoury, (unknown), Derrick J. Rossi, Gregory L. Verdine, Michael K. Mansour, David T Scadden	149
5	Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells breakdown → 2000 ·Nature Biotechnology ·M. Lewin, Nadia Carlesso, Ching‐Hsuan Tung, Xiaowu Tang, David G. Cory, David T Scadden, Ralph Weissleder	1411
6	Extracellular calcium elicits a chemokinetic response from monocytes in vitro and in vivo 2000 ·Journal of Clinical Investigation ·Ivona T. Olszak, Mark C. Poznansky, Richard H. Evans, Douglas P. Olson, Claudine H. Kos, Martin R. Pollak, Edward M. Brown, David T Scadden	133
7	Active movement of T cells away from a chemokine 2000 ·Nature Medicine ·Mark C. Poznansky, Ivona T. Olszak, Russell B. Foxall, Richard H. Evans, Andrew D. Luster, David T Scadden	250
8	Cytotoxic CD8+ T Lymphocytes Reactive with Human Immunodeficiency Virus-1 Produce Granulocyte/Macrophage Colony-Stimulating Factor and Variable Amounts of Interleukins 2, 3, and 4 Following Stimulation with the Cognate Epitope 1995 ·Clinical Immunology and Immunopathology ·(unknown), R. Paul Johnson, David T Scadden, Christian Jassoy, (unknown), Spyros A. Kalams, Bruce D. Walker	9
9	Cloning of FRK, a novel human intracellular SRC-like tyrosine kinaseencoding gene 1994 ·Gene ·James Lee, (unknown), Shiuh-Ming Luoh, (unknown), David T Scadden	50

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact